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Abstract. N-Methyl-N-nitrosourea (MNU) induces a high incidence of mammary adenocarcinomas in 
Sprague-Dawley rats. Our paper describes associated mammary adenocarcinoma and malign lymphoma in 
mammary parenchyma in a Sprague-Dawley female rat inoculated with MNU. After a quarantine period, 
20 rats were selected at random divided into 2 groups (1st and 2nd groups) and housed accordingly. 37 day 
old female Sprague-Dawley rats from the 1st group received a single dose of 55mg MNU/kg body weight. 
At 9.5 months after MNU administration the experiment was ended. Necropsy and histopathological 
examinations were carried out on each rat. The samples harvested for the histopathological examinations 
were fixed in 10% buffered formalin solution and then processed by paraffin technique. Sections were 
stained by Masson’s trichrome and hematoxylin-eosin staining techniques. Mammary tumor induction 
following MNU-inoculation in the 1st group was high (90% of all tumors). In the 1st group were identified 
non-mammary tumors too representing about 10% of all tumors. In one individual of the 1st group were 
diagnosed multiple in situ mammary ductal carcinomas in several mammary glands (tumor size varied 
from 0.8/0.5cm to 7.9/6.5 cm). Following histological examination of all mammary tumors, a diffuse 
infiltrate (with lymphoblasts) extended throughout the tumor mass. The poorly differentiated lymphoblasts 
revealed an invasive character often bordering the tubular cancerous mammary structures. Frequently 
tumoral lymphoblasts induced severe compression atrophy on mammary tumor tubular structures. Based 
on presented histological features an unusual case with both mammary cancer and lymphoma was 
described in a female Sprague-Dawley rat following MNU-inoculation. 
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INTRODUCTION 
 
Studies realized in experimental animal models have confirmed that mammary cancer is 
a compound multistep process that can be induced by chemicals, radiation, viruses, or genetic 
factors. Rodent models have been useful to analyze the initiation, promotion, and progression 
steps of mammary carcinogenesis (Russo et al., 2000). N-Methyl-N-nitrosourea (MNU) induces 
a high incidence of mammary adenocarcinomas in Sprague-Dawley rats.  
A single dose given to sexually immature (35-day-old) female rats is enough to induce 
these tumors (Gullino et al., 1975; McCormick et al., 1981; Sukumar et al., 1983). The Ha-ras 
oncogene, activated by a G -- A transition mutation at the second nucleotide of codon 12, is 
notified in >85% of the tumors (Lu and Archer, 1992). 
Our paper reports concurrent mammary adenocarcinoma and malign lymphoma in 
mammary parenchyma in a Sprague-Dawley female rat inoculated with MNU (i.e., chemically 
induced mammary tumorigenesis), with the gross and microscopic description of the tumors. 
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MATERIALS AND METHODS 
 
After a quarantine period, 20 rats were selected at random divided into 2 groups and 
housed accordingly. 37 day old female Sprague-Dawley rats who are sexually immature received 
a single dose of 55mg MNU/kg body weight (1st group). The 2nd group was the control one. 
Animals from both groups were exsanquinated (after deep narcosis with halothane) at 9.5 months 
after the administration of MNU. Necropsy and histopathological examinations were carried out 
on each rat. The samples harvested for the histopathological examinations were fixed in 10% 
buffered formalin solution. These were processed using the paraffin technique. Sections were 
stained by Masson’s trichrome and hematoxylin-eosin staining techniques. 
 
RESULTS AND DISCUSSION 
 
Mammary tumor induction following MNU-inoculation in the 1st group was high (i.e., 
90% of all tumors) as the bibliography also suggest (Thompson et al., 1997; Thompson et al., 
1998; Thompson, 2000). Excepting mammary tumors, in the 1st group were identified non-
mammary tumors (e.g., kidney fibroma and interstitial renal tumor, uterine leiomyoma, omental 
liposarcoma, ovarian fibrosarcoma) representing about 10% of all tumors.  
However, in one individual of the 1st group were diagnosed multiple in situ mammary 
ductal carcinomas (DCIS) in several mammary glands (i.e., in 2nd and 5th right mammary glands 
and 2nd and 4th left mammary glands). Grossly, the mammary tumor size varied from 0.8/0.5cm 
to 7.9/6.5 cm. The histological pattern of these mammary DCIS varied from cribriform to 
papillary or comedo-carcinoma. In the same subject who had multiple mammary tumors, the 
axillary lymph nodes were hypertrophied. Interestingly, following histological examination of all 
mammary tumors, a diffuse infiltrate (with lymphoblasts) extended throughout the tumor mass.  
Additionally, the poorly differentiated lymphoblasts revealed an invasive character 
often bordering the tubular cancerous mammary structures. Frequently tumoral lymphoblasts 
induced severe compression atrophy on mammary cancerous tubular structures (Figs 1 and 2). 
Based on presented histological features a female Sprague-Dawley rat with both mammary 
cancer and malignant lymphoma was diagnosed. 
 
  
 
Fig. 1 Mammary DCIS (comedocarcinoma 
type) and malign lymphoma invading 
mammary tumor, HE. 
 
Fig.  2 Mammary DCIS (cribriform type) and 
associated malign lymphoma invading 
mammary tumor sustaining stroma, HE.
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A similar aspect of simultaneous mammary carcinomas and mammary lymphoma was 
presented by others following DMBA (7,12-dimethylbenz[α]anthracene)-induced mammary 
tumorigenesis (Qing et al., 1997). Qing et al. (1997) describes two opposite dose-dependent 
relationships between mammary tumor induction and DMBA dose: (1) the higher the dose, the 
higher the lymphoma incidence; (2) the lower the dose, the higher the mammary tumor incidence 
(Qing et al., 1997). Qing et al. (1997) hypothesize that strong and continuing DMBA-induced 
immunosuppression (hormone and other factors may be involved) could be a key element in 
causing lymphoid neoplasia. Comparable aspects have been observed in women by Wiernik et al. 
(2000). The authors mention that in women with both breast cancer and lymphoma, the two 
neoplasms could have a common etiology, possibly viral (Wiernik et al., 2000). 
 
CONCLUSION 
 
In relation with the previously described morphological features, an unusual case with 
both mammary cancer and lymphoma was described in a female Sprague-Dawley rat following 
MNU-inoculation. However, because of the high infrequency of this circumstance, many aspects 
of its pathology stay behind to be elucidated. 
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